These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 11150947

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Risk factors for papaverine-induced priapism.
    Lomas GM, Jarow JP.
    J Urol; 1992 May; 147(5):1280-1. PubMed ID: 1569668
    [Abstract] [Full Text] [Related]

  • 3. The actual incidence of papaverine-induced priapism in patients with erectile dysfunction following penile colour Doppler ultrasonography.
    Kilic M, Serefoglu EC, Ozdemir AT, Balbay MD.
    Andrologia; 2010 Feb; 42(1):1-4. PubMed ID: 20078509
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prolonged erections following intracorporeal injection of medications to overcome impotence.
    Watters GR, Keogh EJ, Carati CJ, Earle CM, Wisniewski ZS, Tulloch AG, Lord DJ.
    Br J Urol; 1988 Aug; 62(2):173-5. PubMed ID: 3408889
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Priapism as a complication following diagnostic papaverine test].
    Darewicz J, Galek L.
    Z Urol Nephrol; 1989 Jun; 82(6):317-9. PubMed ID: 2763728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction.
    Hübler J, Szántó A, Könyves K.
    Int Urol Nephrol; 2003 Jun; 35(4):519-21. PubMed ID: 15198160
    [Abstract] [Full Text] [Related]

  • 13. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1.
    Seyam R, Mohamed K, Akhras AA, Rashwan H.
    Int J Impot Res; 2005 Jun; 17(4):346-53. PubMed ID: 15772683
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of impotence with intracavernous auto-injections: moxisylyte diminishes the risks compared to papaverine].
    Buvat J, Buvat-Herbaut M, Lemaire A, Marcolin G.
    Contracept Fertil Sex; 1993 Feb; 21(2):173-6. PubMed ID: 7951610
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of erectile dysfunction after kidney transplantation with intracavernosal self-injection of prostaglandin E1.
    Mansi MK, Alkhudair WK, Huraib S.
    J Urol; 1998 Jun; 159(6):1927-30. PubMed ID: 9598489
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Priapism following intracavernous injection of vasoactive substances as a urologic emergency].
    Papadopoulos I, Weichert-Jacobsen K, Wand H.
    Z Urol Nephrol; 1990 May; 83(5):233-7. PubMed ID: 2392883
    [Abstract] [Full Text] [Related]

  • 20. [Induction of an erection using papaverine].
    Terek A, Sekei J, Getz F.
    Urol Nefrol (Mosk); 1989 May; (3):69-71. PubMed ID: 2773185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.